Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Acorda Therapeutics, Inc.
Acorda Therapeutics, Inc. Announces Exercise of Option by Underwriter
September 5th, 2008
Acorda Therapeutics, Inc. (NASDAQ: ACOR) (the "Company") announced that Deutsche Bank Securities Inc., as underwriter of the Company's common stock offering that was announced on August 7, 2008, has exercised its entire option to purchase an additional 600,000 shares of common stock at the public offering price of $28.50 per share. The exercise of the option increases the size of the offering to an aggregate of 4,600,000 shares of common stock. Copies of the final prospectus related to the offering may be obtained by contacting Deutsche Bank Securities Inc., Deutsche Bank Securities, Prospectus Department, Harborside Financial Center, 100 Plaza One, Jersey City, New...
Source: Health Business Week (2008-09-05)
|
